Prolonged SARS-CoV-2 RNA detection by RT-PCR: variability in cycle threshold values over time
Open Access
- 7 October 2025
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0122525
Abstract
Millions of reverse transcription-polymerase chain reaction (RT-PCR) tests have been performed worldwide during the SARS-CoV-2 pandemic, using various protocols. This study evaluates the duration of SARS-CoV-2 RNA detectability by RT-PCR at body temperature and analyzes changes in cycle threshold (Ct) values over time. Positive nasopharyngeal swabs for SARS-CoV-2 RT-PCR ( n = 120) with different Ct values were collected from Hospital Universitario 12 de Octubre (Madrid, Spain, 2020). Samples were processed using an open-access protocol for the Hologic Panther Fusion system, targeting the envelope gene. They were stratified into six Ct value groups (40.0) and incubated at 37°C for 15, 30, 45, and 60 days, with RT-PCR repeated at each interval. Samples with Ct 40.0 were negative by day 15. A significant proportion of samples with Ct ≤35.0 remained positive at day 60. Positivity during incubation decreased with higher Ct values ( P < 0.001). Ct values increased over time but inconsistently by day 60. In conclusion, SARS-CoV-2 RNA can persist for months, leading to prolonged RT-PCR positivity. However, repeated RT-PCR testing introduces variability in qualitative results and Ct values, complicating clinical decisions. Patient monitoring should emphasize clinical assessment and viral viability assays rather than repeated RT-PCR testing. IMPORTANCE: This study investigates the prolonged persistence of SARS-CoV-2 detected by reverse transcription-PCR (RT-PCR) at human body temperature and the evolution of cycle threshold (Ct) values in positive respiratory samples. Our findings indicate that SARS-CoV-2 RNA can persist for months, and that repeated RT-PCR testing over time introduces variability, particularly in samples with high Ct values. This work highlights the necessity of complementing RT-PCR testing with methods assessing viral viability to avoid over-reliance on repeated testing in clinical decision-making. This study addresses a critical issue in COVID-19 diagnostics, with important implications for clinical management and infection control.Keywords
Funding Information
- Instituto de Salud Carlos III (2101892)
This publication has 9 references indexed in Scilit:
- Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabsMicrobiology Spectrum, 2024
- Persistent SARS-CoV-2 infection: significance and implicationsThe Lancet Infectious Diseases, 2024
- Cycle threshold of SARS-CoV-2 RT-PCR as a driver of retestingScientific Reports, 2024
- The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023)Clinical Infectious Diseases, 2023
- Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold ValuesJournal of Clinical Microbiology, 2022
- Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction AssaysClinics In Laboratory Medicine, 2022
- Diagnostics for COVID-19: moving from pandemic response to controlThe Lancet, 2021
- Coronavirus Disease 2019–COVID-19Clinical Microbiology Reviews, 2020
- Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther FusionJournal of Clinical Virology, 2020